Cargando…

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)

Epithelial ovarian cancer (EOC) is a significant cause of cancer related morbidity and mortality in women. Preferential involvement of peritoneal structures contributes to the overall poor outcome in EOC patients. Advances in biotechnology, such as cDNA microarray, are a product of the Human Genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freedman, Ralph S, Deavers, Michael, Liu, Jinsong, Wang, Ena
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC459521/ https://www.ncbi.nlm.nih.gov/pubmed/15219235 http://dx.doi.org/10.1186/1479-5876-2-23

Ejemplares similares

The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
por: Peng, Peng, et al.
Publicado: (2019)

Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis
por: Fahmi, Moh Nailul, et al.
Publicado: (2021)

Ovarian cancer, the coagulation pathway, and inflammation
por: Wang, Xipeng, et al.
Publicado: (2005)

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)
por: Jim, Heather S.L., et al.
Publicado: (2015)

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
por: Chornokur, Ganna, et al.
Publicado: (2015)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
por: Wang, Xipeng, et al.
Publicado: (2006)

Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses
por: Chen, Zhonghua, et al.
Publicado: (2020)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases
por: Chen, Junyu, et al.
Publicado: (2021)

FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization
por: Xie, Xiaohui, et al.
Publicado: (2021)

Tumor microenvironment in ovarian cancer peritoneal metastasis
por: Mei, Shuangshuang, et al.
Publicado: (2023)

SOS1 promotes epithelial-mesenchymal transition of Epithelial Ovarian Cancer(EOC) cells through AKT independent NF-κB signaling pathway
por: Cheng, Min, et al.
Publicado: (2021)

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
por: Teng, Yue, et al.
Publicado: (2016)

Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
por: Gargosky, Sharron, et al.
Publicado: (2014)

The Overtreatment and Cost Effectiveness of Primary versus Secondary Maintenance Therapy with Poly-Adenosine Ribose Phosphate Inhibitors (PARPi) for Epithelial Ovarian Cancer (EOC)
por: Rose, Peter G, et al.
Publicado: (2021)

LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway
por: Mehdi, Sadia, et al.
Publicado: (2020)

MUC16 promotes EOC proliferation by regulating GLUT1 expression
por: Wang, Fang, et al.
Publicado: (2021)

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
por: Xu, Yan
Publicado: (2018)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)

Microbial infection, inflammation and epithelial ovarian cancer
por: Xie, Xiaohui, et al.
Publicado: (2017)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment
por: Harper, Elizabeth I., et al.
Publicado: (2018)

CISD2 Attenuates Inflammation and Regulates Microglia Polarization in EOC Microglial Cells—As a Potential Therapeutic Target for Neurodegenerative Dementia
por: Lin, Muh-Shi
Publicado: (2020)

Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
por: Hilliard, Tyvette S., et al.
Publicado: (2021)

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
por: Gore, Martin, et al.
Publicado: (2019)

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
por: Mehdi, Sadia, et al.
Publicado: (2020)

Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance
por: Liu, Yu, et al.
Publicado: (2018)

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2
por: He, Wei-Peng, et al.
Publicado: (2020)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer
por: Asem, Marwa, et al.
Publicado: (2020)

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
por: Lenzi, Renato, et al.
Publicado: (2007)

The Endometriotic Tumor Microenvironment in Ovarian Cancer
por: Wendel, Jillian R. Hufgard, et al.
Publicado: (2018)

The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells
por: Jen, Huan-I, et al.
Publicado: (2020)

Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis
por: Yoshida, Mitsuyo, et al.
Publicado: (2016)

Pretreatment CT differential diagnosis of tuberculous peritonitis from peritoneal carcinomatosis of advanced epithelial ovarian cancer
por: Lee, Chul-min, et al.
Publicado: (2023)

Role of tumor microenvironment in ovarian cancer pathobiology
por: Ghoneum, Alia, et al.
Publicado: (2018)

Role of exosomes in the immune microenvironment of ovarian cancer
por: Li, Xiao, et al.
Publicado: (2021)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r24ljojdhgb6sjgrnua8j2f97a